Esophageal Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5103-5108
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5103
Table 1 Demographic characteristics among 134 cases and 237 controls
VariablesCases (%)n = 134Controls (%)n = 237Crude OR (95%CI)P
Age (yr)
Mean±SD58.9±12.657.8±11.80.41
Education (%)
<High school107 (76.1)86 (36.3)1
High school23 (17.1)94 (39.7)0.20 (0.11–0.34)
>High school4 (3.0)57 (24.1)0.06 (0.06–0.16)<0.0001
Ethnicity (%)
Mainlander102 (76.1)186 (78.5)1
Fukienese25 (18.7)33 (13.9)1.38 (0.78–2.45)
Others7 (5.2)18 (7.6)0.71 (0.29–1.75)0.37
Cigarette smoking (%)
No10 (7.5)124 (52.3)1
Yes124 (92.5)113 (47.7)13.61 (6.81–27.21)<0.0001
Alcohol consumption (%)
No24 (17.9)162 (68.4)1
Yes110 (82.1)75 (31.6)9.9 (5.89–16.64)<0.0001
Areca chewing (%)
No66 (49.3)220 (92.8)1
Yes68 (50.8)17 (7.2)13.33 (7.33–24.26)<0.0001
Table 2 Association of ADH2 and ALDH2 genotypes with esophageal cancer risk before and after adjusting for other covariates
GenotypesCases (%) n = 134Controls (%) n = 237OR (95%CI)AOR (95%CI)1
ADH2
*2/*246 (34.3)130 (54.9)11
*1/*249 (36.6)91 (38.4)1.52 (0.94–2.47)2.28 (1.11–4.68)
*1/*139 (29.1)16 (6.8)6.89 (3.52–13.49)7.14 (2.76–18.46)
P for HW21.00
ALDH2
*1/*132 (23.9)120 (50.6)11
*1/*299 (73.9)105 (44.3)3.54 (2.19–5.70)5.25 (2.47–11.19)
*2/*23 (2.2)12 (5.1)0.94 (0.25–3.52)2.44 (0.44–13.55)
P for HW20.38
Table 3 Joint effect of ADH2 and ALDH2 genotypes on esophageal cancer risk
ADH2ALDH2Cases (%) n = 134Controls (%) n = 237OR (95%CI)AOR (95%CI)1
*1/*2 or *2/*2*1/*123 (17.2)112 (47.3)11
*1/*19 (6.7)8 (3.4)4.20 (1.49–11.81)3.54 (0.93–13.53)
*1/*2 or *2/*2*1/*269 (51.5)98 (41.4)2.63 (1.58–4.37)4.81 (2.17–10.70)
*1/*130 (22.4)7 (3.0)16.00 (6.40–39.99)36.79 (9.36–144.65)
*1/*2 or *2/*2*2/*23 (2.2)11 (4.6)1.02 (0.27–3.88)3.40 (0.63–18.33)
*1/*101 (0.4)
Table 4 Interactive effect between lifetime alcohol consumption and ADH2 and ALDH2 genotypes on esophageal cancer risk
ADH2ALDH2Alcohol consumption (g/yr)Cases (%) n = 134Controls (%) n = 237OR (95%CI)AOR (95%CI)1
*1/*2 or *2/*2*1/*1Non-drinker3 (2.2)66 (27.9)11
≤1 5005 (3.7)19 (8.0)5.79 (1.27-26.46)3.76 (0.65-21.69)
>1 50015 (11.2)27 (11.4)12.22 (3.27-45.66)6.07 (1.46-25.26)
*1/*1*1/*1Non-drinker02 (0.8)
≤1 5004 (3.0)4 (1.7)22.00 (3.62-133.81)14.91 (1.92-115.95)
>1 5005 (3.7)2 (0.8)55.00 (7.39-409.22)33.54 (3.52-319.89)
*1/*2 or *2/*2*1/*2Non-drinker13 (9.7)76 (32.1)3.76 (1.03-13.78)2.92 (0.73-11.63)
≤1 50031 (23.1)15 (6.3)45.47 (12.26-168.68)26.67 (6.05-117.57)
>1 50025 (18.7)7 (3.0)78.57 (18.83-327.89)39.26 (7.05-218.68)
*1/*1*1/*2Non-drinker5 (3.7)6 (2.5)18.33 (3.50-96.18)18.60 (2.69-128.77)
≤1 50014 (10.5)1 (0.4)308 (29.80-3 183.05)139.35 (10.05-∞)
>1 50011 (8.2)0
*1/*2 or *2/*2*2/*2Non-drinker3 (2.2)11 (4.6)6 (1.07-33.60)2.20 (0.33-14.47)
≤1 50000
>1 50000
*1/*1*2/*2Non-drinker01 (0.4)
≤1 50000
>1 50000
Table 5 Allele frequencies of ADH2 and ALDH2 genotypes among different racial groups
PopulationsADH2
ALDH2
n*1/*2 (%)n*1/*2 (%)
Germans12330.96/0.041931/0
Indians11670.90/0.101790.98/0.02
Chinese1860.32/0.681320.84/0.16
Japanese24610.07/0.934610.58/0.42
Taiwanese3470.27/0.73470.70/0.30
Our study2370.26/0.742370.73/0.27